APA (7th ed.) Citation

Bressler, S. B., Liu, D., Glassman, A. R., Blodi, B. A., Castellarin, A. A., Jampol, L. M., . . . Wells, J. A. (2017). Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab. JAMA ophthalmology, 135(6), 558. https://doi.org/10.1001/jamaophthalmol.2017.0821

Chicago Style (17th ed.) Citation

Bressler, Susan B., et al. "Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab." JAMA Ophthalmology 135, no. 6 (2017): 558. https://doi.org/10.1001/jamaophthalmol.2017.0821.

MLA (9th ed.) Citation

Bressler, Susan B., et al. "Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab." JAMA Ophthalmology, vol. 135, no. 6, 2017, p. 558, https://doi.org/10.1001/jamaophthalmol.2017.0821.